Wisconsin State Laboratory of Hygiene. WISCONSIN STATE LABORATORY OF HYGIENE Case Study Youngmi Kim, MS, ASCP(M) Senior Microbiologist, Wisconsin State.

Slides:



Advertisements
Similar presentations
Molecular testing for detection of Mycobacterium tuberculosis San Francisco Department of Public Health Laboratory.
Advertisements

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers.
Continuity Clinic Tuberculosis. Continuity Clinic Objectives Know current epidemiologic trends in TB Know indications for testing for TB exposure and.
MDCH STATE LABORATORY TUBERCULOSIS TESTING Specimens/Tests/Reports
Nucleic Acid Amplification Test for Tuberculosis
Case discussion Michael Gardam University Health Network.
OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,
Sheboygan County 2013 Sandy Muesegades, RN – Public Health Nurse.
Development of extensive drug resistance in Multi-Drug resistant tuberculosis patients MSF anti-TB programmes in Abkhazia and Uzbekistan Authors: Cathy.
ISDH Lab TB Testing Update Lixia Liu PhD MP(ASCP) September 16, 2010.
Introduction to Tuberculosis
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
4 th National Anti-tuberculosis Drug Resistance Survey Botswana, 2007.
MAC PCR at WSLH Julie Tans-Kersten, MS, BS-MT (ASCP)
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
PRE-EXTENSIVELY DRUG RESISTANT (XDR) TB IN WISCONSIN  Marathon County  Population 134,700  1,545 square miles  Marathon County Health Department 
Comparison of Molecular and Conventional Methods for Detection of Multidrug-Resistant Tuberculosis in the United States, 2009 to 2011 Mitchell A. Yakrus,
British Society for Microbial Technology The laboratory diagnosis of tuberculosis 25 years of progress D A Mitchison St George’s, University of London.
Microbiologists from Mexico at South Texas Hospital Lab “Microbiólogos de México en el laboratorio de South Texas Hospital”
Tuberculosis Research of INA-RESPOND on Drug-resistant
TB Control Program County of San Diego Challenges: Cross border Continuity of TB Care Response:CureTBUS/Mexico Tuberculosis Referral and Information Program.
WISCONSIN STATE LABORATORY OF HYGIENE 1 WSLH: Laboratory Update Tuberculosis Summit Verona, WI April 24, 2014 Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis.
CLINICAL DIAGNOSTIC TB LABORATORY Alexander Sloutsky, Director University of Massachusetts Supranational Reference TB Laboratory Boston, MA.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Progress of the Singapore TB Elimination Programme (STEP)
Tuberculosis in Virginia? Wendy Heirendt, MPA Public Health Advisor Division of TB Control Virginia Department of Health September 12, 2005.
WISCONSIN STATE LABORATORY OF HYGIENE 1 State Lab Perspective Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Management of Tuberculosis: A Surgical Perspective Alfred Lardizabal, MD Associate Professor Division of Pulmonary and Critical Care Medicine UMDNJ-NJ.
Screening for TB.
بسم الله الرحمن الرحيم. A 25 year old Saudi male applied to work as paramedic. He has no symptoms or history of contact with sick patients. His physical.
Revision of new diagnostics for TB
Infectious Conditions of the Lower Respiratory Tract.
S. Vashakidze, N. Shubladze, L.Kupreishvili,K.Nikolaishvili, L. Mskhiladze, I.Khurtsilava, *J. E. Graham, National Center of TB and Lung Diseases, Tbilisi,Georgia.
Tuberculosis Case Study Presenter Xoliswa Poswa TB Laboratory, NHLS/CMID.
Diagnostic Tests Chest x-ray –Patchy or nodular infiltrate –Apical or sub-apical posterior aspects of UPPER LOBES (or superior segment of lower.
Kaiser Oakland Contact Investigation CTCA Conference May 6 th, 2010 Tara Greenhow, MD Pediatric Infectious Diseases Kaiser Permanente San Francisco.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Patient with Presumptive TB HIV Status PositiveNegative % Empiric Tx of Patients with Active TB % Empiric Tx of TB-Symptomatic Patients without True TB.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
The Epidemiology of Tuberculosis Lex Gibson, Director Virginia TB Program.
Diagnosis of pulmonary tuberculosis
EPIDEMIOLOGY OF PULMONARY TUBERCULOSIS. LEARNIN G OBJECTIVES State the diagnostic criteria of pulmonary tuberculosis Describe trend & state reasons for.
Management of the Newborn When Maternal TB Suspected
Management of Tuberculosis: A Surgical Perspective
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Infant born with mother Tuberculosis
This is an archived document.
Treatment of Latent TB Infection (LTBI)
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
Laboratory Testing for Tuberculosis
Laboratory ‘Network’ Update New York State Department of Health
Epidemiology of pulmonary tuberculosis
2017 World TB Day Jessica Gentry Tuberculosis Laboratory Supervisor
بسم الله الرحمن الرحيم.
Module 9 Recording and reporting culture results
Hidalgo County Hospital TB Outbreak Investigation
Tb: Screening & Diagnosis (1)
Deciphering TB Lab Reports
Tuberculosis Control Program
Jessica Gentry Tuberculosis Laboratory Supervisor
Presentation transcript:

Wisconsin State Laboratory of Hygiene

WISCONSIN STATE LABORATORY OF HYGIENE Case Study Youngmi Kim, MS, ASCP(M) Senior Microbiologist, Wisconsin State Laboratory of Hygiene 2

WISCONSIN STATE LABORATORY OF HYGIENE 3 31 year old female from Kenosha County Strong TB suspect: foreign born, abnormal CXR, positive QFT Received sputa for smear and culture collected 2/20, 2/21, and 2/22/13

WISCONSIN STATE LABORATORY OF HYGIENE Two of the three specimens were smear positive (1+ and 3+), but TB PCR was negative for both Specimen sent to CA PHL for parallel testing (WI & CA Shared Services Project) –NAAT –MDDR (CA only) –Conventional TB DST 4

WISCONSIN STATE LABORATORY OF HYGIENE CA lab had a weak positive NAAT result and contacted WI SLH for more information on the patient. California was hesitant to send out a positive result, given WSLH’s TB PCR results (both negative). CA report 3/1/13: “identification of MTB is inconclusive”. 5

WISCONSIN STATE LABORATORY OF HYGIENE MGIT became positive (GU=2278) 3/4/13 6

WISCONSIN STATE LABORATORY OF HYGIENE 7

HPLC:Prelim reported as MAIS 3/6/13 Positive MGIT growth subcultured to »7H10, LJ, & 7H9 8

WISCONSIN STATE LABORATORY OF HYGIENE 3/12/13: Small colonies with cording in 1 st quadrant noticed amongst the confluent MAC growth 9

WISCONSIN STATE LABORATORY OF HYGIENE 3 rd Quadrant of 7H10 plate 10

WISCONSIN STATE LABORATORY OF HYGIENE 3/12/13: TB PCR performed from MGIT broth was positive for M. tbc (Ct=22) Tried very hard to isolate M. tbc for susceptibility testing –Growth in broth containing clarithromycin –Growth on plate with clarithromycin disk 11

WISCONSIN STATE LABORATORY OF HYGIENE 4/15/13 at WSLH: M. tbc isolated & 1 st line DST set up (49 days after receipt) CA PHL report 3/18/13: –MDDR testing: no mutations that confer resistance to INH, rifampin, quinolones or injectables 12

WISCONSIN STATE LABORATORY OF HYGIENE 4/25/13 –1 st line DST result out as pan susceptible to all 4 drugs 13

WISCONSIN STATE LABORATORY OF HYGIENE Specime n # (All Sputum) DOCSmearCulture 13MM18112/20/13NegMAC & M. tbc 13MM18352/21/131-9/ fMAC & M. tbc 13MM18642/22/131-9/100 fMAC 13MM21893/15/13NegMAC 13MM25804/9/131-9/100 fMAC 13MM25794/10/13QuestionableMAC 13MM26064/11/13NegMAC 13MM27124/17/13NegMAC 13MM28094/23/131-9/100 fMAC 13MM29404/30/13NegMAC 13MM30035/6/13NegMAC 13MM31525/10/13NegMAC 14

WISCONSIN STATE LABORATORY OF HYGIENE Questions for County PHN Any signs and symptoms? 15

WISCONSIN STATE LABORATORY OF HYGIENE Questions for County PHN Any signs and symptoms? –No 16

WISCONSIN STATE LABORATORY OF HYGIENE Questions for County PHN Why was sputum collected? 17

WISCONSIN STATE LABORATORY OF HYGIENE Questions for County PHN Why was sputum collected? –Pre-employment screening at a nursing home –Patient refused skin test due to BCG vacc. –CXRAbnormal –QTF + –3 Sputa collected –2 of 3 Smear Positive 18

WISCONSIN STATE LABORATORY OF HYGIENE TB Risk Factors -came from Cameroon 2 yrs ago -Husband with 2 sons (also pregnant) Husband: CXR Neg, QFT Neg 5 yr old:CXR a little abnormal QFT Pos 1.5 yr old: CXR Neg, QFT Neg 19

WISCONSIN STATE LABORATORY OF HYGIENE Patient Status Positive culture for M. tbc on 3/13/13 Patient pulled out of employment and placed in respiratory isolation Contact investigation: 80 residents and 100 staff members skin tested; all negative Patient on 3 drug regimen (no PZA) –Till end of Dec / DOT –Refused 5 year old son to be treated –Had a daughter and breast feeding 20